That raises an interesting point. Inflammation serves useful purposes, so when these medications and peptides reduce it, is the effect helpful or potentially harmful in the long run?
A recent New York Times piece discusses how GLP-1 medications have shifted thinking on inflammation control. These drugs seem to ease ongoing inflammation in the body while leaving the immune system able to handle infections normally. Patients using them for diabetes or weight loss often notice improvements in other long-standing health issues as well.